{"title":"Medicare at 60: Suggestions for balancing access to care and financial protections with fiscal concerns","authors":"Michael E. Chernew PhD, Paul B. Masi MPP","doi":"10.1111/1475-6773.14415","DOIUrl":null,"url":null,"abstract":"<p>For 60 years, Medicare has been a cornerstone of the American social insurance system, protecting millions of aged, blind, and disabled people from high health care costs and ensuring access to necessary services. Prior to the creation of Medicare, nearly half of all people aged 65 and older were uninsured.<span><sup>1</sup></span> Today, less than 1% of the elderly population is uninsured.<span><sup>2</sup></span> More broadly, Medicare influences the U.S. health care system, affecting provider supply, payment rates and methods, and care delivery institutions.</p><p>Recent news about Medicare's fiscal situation has been encouraging. Since 2021, the projected date of depletion of the Medicare Part A trust fund has been pushed back by 10 years, from 2026 to 2036.<span><sup>3</sup></span> More importantly, Medicare spending per beneficiary has grown relatively slowly over the last 10 to 15 years, due to factors such as smaller increases in payment rates for many services, slower-than-expected growth in the volume of services, demographic changes in the Medicare population, better treatment of cardiovascular disease, a decline in new drug introductions, and a shift to generic medications.<span><sup>4, 5</sup></span></p><p>Despite these positive trends, Medicare still faces significant fiscal challenges. The program's demographic challenges are well known. Since Medicare's founding, the worker-to-beneficiary ratio has dropped from 4.6 to 2.9 and is projected to fall to 2.5 by 2030.<span><sup>6, 7</sup></span> Medicare spending as a share of GDP has grown from around 0.7% to 3.7% since the program's inception and now accounts for 14% of the federal budget.<span><sup>8, 9</sup></span> More concerning to those worried about the fiscal burden of Medicare, is that, while forecasting spending is inherently challenging, projections suggest a significant increase in Medicare spending over the next decade.</p><p>Moreover, some of the factors contributing to the slower recent growth in per-beneficiary spending may not be sustainable. For example, inflation-adjusted physician fees have declined significantly in recent years.<span><sup>10</sup></span> Access to physician services has remained adequate during this period, but the relatively low increases in payment rates that physicians are slated to receive in the future may not be sustainable as concerns about access to primary care grow and payment rates reduce the viability of independent practice, encouraging physicians to seek employment from larger organizations.<span><sup>11</sup></span> When certain physician practices are purchased by health systems, Medicare's payments commonly shift from the physician fee schedule to the outpatient prospective payment system, which increases spending. Similarly, because of the productivity adjustments to the payment systems adopted in the Affordable Care Act, inflation-adjusted hospital payment rates have grown slowly relative to hospitals' costs which has contributed to negative Medicare margins for many hospitals as well as some hospital closures. These low payment rate trajectories may not be sustainable.<span><sup>12</sup></span> Additionally, the recent introduction of new medications for conditions such as cancer, Alzheimer's disease, and diabetes may lead to higher spending growth for drugs in the future than in the past decade.</p><p>Overall, CMS projects that, under current law, after adjusting for inflation, spending for Part A and Part B services will rise by an average of 4.5% annually between 2023 and 2032, driven entirely by growth in the number of beneficiaries and growth in the volume and intensity of services used. Medicare's prices, under current law, are projected to decline by 0.7% annually over this period after adjusting for inflation.<span><sup>13</sup></span></p><p>In short, the tension between a desire to limit Medicare spending growth and the twin goals of providing financial protection and access to care for beneficiaries is as salient today as ever. The ability of the Medicare program to address growing fiscal pressures while continuing to meet its objectives will require reforms in many areas of the program.</p><p>Below, we highlight some of the recommendations from the Medicare Payment Advisory Commission (MedPAC), an independent congressional agency that advises Congress on issues affecting the Medicare program, aimed at addressing Medicare's challenges and their implications for future policymaking for this critically important program. Though the different parts of Medicare are interrelated, we first present recommendations related to the traditional Medicare program (TM), followed by recommendations for the Medicare Advantage program, which enrolls about half of all Medicare beneficiaries in private health plans. We do not emphasize policies related to prescription drugs because major reforms (including the redesign of part D and other policies included in the Inflation Reduction Act) have recently been enacted, and it will take to time to assess the effects of these reforms. That said, MedPAC has recommended reforms related to Medicare's payments for drugs approved through the accelerated approval process due to concerns around the completion of confirmatory trials. Similarly, we do not discuss options for raising revenue for Medicare, such as tax increases, because MedPAC has not made related recommendations. However, given projected changes in demographics, policymakers may choose to include revenues as part of shoring up Medicare's solvency. This underscores the need for efficient use of Medicare resources.</p><p>The TM program gives beneficiaries a broad choice of providers (the vast majority of hospitals and physicians participate) but does not provide any additional benefits beyond the standard package. By contrast, private Medicare Advantage (MA) plans can require enrollees to obtain care from in-network providers and employ utilization management tools such as prior authorization, but they also offer a wide array of extra benefits that TM does not cover. MA enrollment has grown substantially over the past decade and a majority of beneficiaries with both Part A and Part B coverage are now in MA plans. In some markets, MA participation exceeds 80%.</p><p>When private plans were added to the Medicare program, they were viewed as a way to produce both program savings (by managing service use and potentially negotiating more favorable payment rates) and provide extra benefits to enrollees (which would be financed using a portion of the savings that plans achieved). However, MedPAC has found that the Medicare Advantage program (and its predecessors), in aggregate, have never saved Medicare money—payments to plans have always been higher than the amount Medicare would have spent to cover the same beneficiaries in TM. In March 2024, the Commission estimated that payments to MA plans are 22% higher than TM costs, stemming largely from relative coding intensity and favorable selection into MA of beneficiaries with lower-than-expected spending.<span><sup>24</sup></span> These higher payments have allowed MA plans to offer increasingly generous supplemental benefits and better financial protection for MA enrollees, such as lower cost sharing and reduced premiums. This has led to steady growth in MA enrollment.<span><sup>25</sup></span></p><p>Apart from these recommendations, MedPAC acknowledges that if enrollment in MA continues to grow, a more fundamental redesign of the MA program will be needed because setting MA benchmarks based on a shrinking TM program will become increasingly problematic. Policy makers may need to consider options such as competitive bidding, using MA data to set payments, or using administrative benchmarks.<span><sup>31</sup></span></p><p>For 60 years, Medicare has been a pillar of the American social insurance system. It has provided generations of Americans with financial protection from illness and enabled them to access needed care. Yet, as the baby boomers age into the program and medical science continues to produce important, health-improving innovations that must be financed, the Medicare program needs to continue evolving to promote efficient care delivery while continuing to ensure access and financial protection. There are no silver bullet solutions, but the approaches above suggest ways to improve incentives for efficient delivery of care, improve beneficiary access to high-quality care, increase competition, and improve the program's fiscal situation.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"60 S2","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1475-6773.14415","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Services Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1475-6773.14415","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
For 60 years, Medicare has been a cornerstone of the American social insurance system, protecting millions of aged, blind, and disabled people from high health care costs and ensuring access to necessary services. Prior to the creation of Medicare, nearly half of all people aged 65 and older were uninsured.1 Today, less than 1% of the elderly population is uninsured.2 More broadly, Medicare influences the U.S. health care system, affecting provider supply, payment rates and methods, and care delivery institutions.
Recent news about Medicare's fiscal situation has been encouraging. Since 2021, the projected date of depletion of the Medicare Part A trust fund has been pushed back by 10 years, from 2026 to 2036.3 More importantly, Medicare spending per beneficiary has grown relatively slowly over the last 10 to 15 years, due to factors such as smaller increases in payment rates for many services, slower-than-expected growth in the volume of services, demographic changes in the Medicare population, better treatment of cardiovascular disease, a decline in new drug introductions, and a shift to generic medications.4, 5
Despite these positive trends, Medicare still faces significant fiscal challenges. The program's demographic challenges are well known. Since Medicare's founding, the worker-to-beneficiary ratio has dropped from 4.6 to 2.9 and is projected to fall to 2.5 by 2030.6, 7 Medicare spending as a share of GDP has grown from around 0.7% to 3.7% since the program's inception and now accounts for 14% of the federal budget.8, 9 More concerning to those worried about the fiscal burden of Medicare, is that, while forecasting spending is inherently challenging, projections suggest a significant increase in Medicare spending over the next decade.
Moreover, some of the factors contributing to the slower recent growth in per-beneficiary spending may not be sustainable. For example, inflation-adjusted physician fees have declined significantly in recent years.10 Access to physician services has remained adequate during this period, but the relatively low increases in payment rates that physicians are slated to receive in the future may not be sustainable as concerns about access to primary care grow and payment rates reduce the viability of independent practice, encouraging physicians to seek employment from larger organizations.11 When certain physician practices are purchased by health systems, Medicare's payments commonly shift from the physician fee schedule to the outpatient prospective payment system, which increases spending. Similarly, because of the productivity adjustments to the payment systems adopted in the Affordable Care Act, inflation-adjusted hospital payment rates have grown slowly relative to hospitals' costs which has contributed to negative Medicare margins for many hospitals as well as some hospital closures. These low payment rate trajectories may not be sustainable.12 Additionally, the recent introduction of new medications for conditions such as cancer, Alzheimer's disease, and diabetes may lead to higher spending growth for drugs in the future than in the past decade.
Overall, CMS projects that, under current law, after adjusting for inflation, spending for Part A and Part B services will rise by an average of 4.5% annually between 2023 and 2032, driven entirely by growth in the number of beneficiaries and growth in the volume and intensity of services used. Medicare's prices, under current law, are projected to decline by 0.7% annually over this period after adjusting for inflation.13
In short, the tension between a desire to limit Medicare spending growth and the twin goals of providing financial protection and access to care for beneficiaries is as salient today as ever. The ability of the Medicare program to address growing fiscal pressures while continuing to meet its objectives will require reforms in many areas of the program.
Below, we highlight some of the recommendations from the Medicare Payment Advisory Commission (MedPAC), an independent congressional agency that advises Congress on issues affecting the Medicare program, aimed at addressing Medicare's challenges and their implications for future policymaking for this critically important program. Though the different parts of Medicare are interrelated, we first present recommendations related to the traditional Medicare program (TM), followed by recommendations for the Medicare Advantage program, which enrolls about half of all Medicare beneficiaries in private health plans. We do not emphasize policies related to prescription drugs because major reforms (including the redesign of part D and other policies included in the Inflation Reduction Act) have recently been enacted, and it will take to time to assess the effects of these reforms. That said, MedPAC has recommended reforms related to Medicare's payments for drugs approved through the accelerated approval process due to concerns around the completion of confirmatory trials. Similarly, we do not discuss options for raising revenue for Medicare, such as tax increases, because MedPAC has not made related recommendations. However, given projected changes in demographics, policymakers may choose to include revenues as part of shoring up Medicare's solvency. This underscores the need for efficient use of Medicare resources.
The TM program gives beneficiaries a broad choice of providers (the vast majority of hospitals and physicians participate) but does not provide any additional benefits beyond the standard package. By contrast, private Medicare Advantage (MA) plans can require enrollees to obtain care from in-network providers and employ utilization management tools such as prior authorization, but they also offer a wide array of extra benefits that TM does not cover. MA enrollment has grown substantially over the past decade and a majority of beneficiaries with both Part A and Part B coverage are now in MA plans. In some markets, MA participation exceeds 80%.
When private plans were added to the Medicare program, they were viewed as a way to produce both program savings (by managing service use and potentially negotiating more favorable payment rates) and provide extra benefits to enrollees (which would be financed using a portion of the savings that plans achieved). However, MedPAC has found that the Medicare Advantage program (and its predecessors), in aggregate, have never saved Medicare money—payments to plans have always been higher than the amount Medicare would have spent to cover the same beneficiaries in TM. In March 2024, the Commission estimated that payments to MA plans are 22% higher than TM costs, stemming largely from relative coding intensity and favorable selection into MA of beneficiaries with lower-than-expected spending.24 These higher payments have allowed MA plans to offer increasingly generous supplemental benefits and better financial protection for MA enrollees, such as lower cost sharing and reduced premiums. This has led to steady growth in MA enrollment.25
Apart from these recommendations, MedPAC acknowledges that if enrollment in MA continues to grow, a more fundamental redesign of the MA program will be needed because setting MA benchmarks based on a shrinking TM program will become increasingly problematic. Policy makers may need to consider options such as competitive bidding, using MA data to set payments, or using administrative benchmarks.31
For 60 years, Medicare has been a pillar of the American social insurance system. It has provided generations of Americans with financial protection from illness and enabled them to access needed care. Yet, as the baby boomers age into the program and medical science continues to produce important, health-improving innovations that must be financed, the Medicare program needs to continue evolving to promote efficient care delivery while continuing to ensure access and financial protection. There are no silver bullet solutions, but the approaches above suggest ways to improve incentives for efficient delivery of care, improve beneficiary access to high-quality care, increase competition, and improve the program's fiscal situation.
60年来,医疗保险一直是美国社会保险体系的基石,保护数百万老年人、盲人和残疾人免受高额医疗保健费用的影响,并确保他们获得必要的服务。在医疗保险制度建立之前,65岁及以上的人中有近一半没有保险今天,只有不到1%的老年人口没有保险更广泛地说,医疗保险影响着美国的医疗保健系统,影响着提供者的供应、支付率和方法,以及医疗服务机构。最近有关联邦医疗保险财政状况的消息令人鼓舞。自2021年以来,医疗保险A部分信托基金的预计耗尽日期已被推迟了10年,从2026年推迟到2036.3年。更重要的是,在过去10至15年里,由于许多服务的支付率增幅较小、服务量增长低于预期、医疗保险人口的人口变化、心血管疾病治疗的改善、医疗保险受益人的支出增长相对缓慢。新药引进的减少,以及向仿制药的转变。4,5尽管有这些积极的趋势,医疗保险仍然面临着重大的财政挑战。这个项目面临的人口挑战是众所周知的。自联邦医疗保险成立以来,工人与受益人的比率已从4.6降至2.9,预计到2030年将降至2.5。自该计划启动以来,联邦医疗保险支出占GDP的比例已从0.7%左右上升至3.7%,目前占联邦预算的14%。8,9对于那些担心医疗保险财政负担的人来说,更令人担忧的是,虽然预测支出本身就具有挑战性,但预测表明,未来十年医疗保险支出将大幅增加。此外,导致最近人均受益支出增长放缓的一些因素可能无法持续。例如,近年来,经通货膨胀调整后的医生费用显著下降在此期间,获得医生服务的机会仍然充足,但由于对获得初级保健的关注增加,支付率降低了独立实践的可行性,鼓励医生从更大的组织中寻求就业机会,医生预期在未来获得的报酬率相对较低的增长可能无法持续当医疗系统购买某些医生的服务时,医疗保险的支付通常会从医生收费表转移到门诊预期支付系统,这增加了支出。同样,由于《平价医疗法案》(Affordable Care Act)对支付系统进行了生产力调整,经通胀调整后的医院支付率相对于医院成本增长缓慢,这导致许多医院的医疗保险利润率为负,一些医院也因此关闭。这些低支付率的轨迹可能无法持续此外,最近针对癌症、阿尔茨海默病和糖尿病等疾病的新药物的引入,可能会导致未来药物支出的增长高于过去十年。总体而言,CMS项目,根据现行法律,调整通货膨胀后,在2023年和2032年之间,A部分和B部分服务的支出将平均每年增长4.5%,这完全是由受益人人数的增长以及使用服务的数量和强度的增长所驱动的。根据现行法律,经通货膨胀调整后,在此期间,医疗保险的价格预计将以每年0.7%的速度下降。简而言之,限制医疗保险支出增长的愿望与为受益人提供财务保护和获得医疗服务的双重目标之间的紧张关系,今天与以往一样突出。医疗保险计划在解决日益增长的财政压力的同时继续实现其目标的能力将需要在该计划的许多领域进行改革。下面,我们将重点介绍医疗保险支付咨询委员会(MedPAC)的一些建议。MedPAC是一个独立的国会机构,就影响医疗保险计划的问题向国会提供建议,旨在解决医疗保险面临的挑战及其对这一至关重要的计划未来政策制定的影响。虽然医疗保险的不同部分是相互关联的,但我们首先提出与传统医疗保险计划(TM)相关的建议,然后是医疗保险优势计划的建议,该计划将大约一半的医疗保险受益人纳入私人健康计划。我们不强调与处方药相关的政策,因为重大改革(包括重新设计D部分和《通货膨胀减少法案》中包括的其他政策)最近已经颁布,需要时间来评估这些改革的效果。也就是说,MedPAC已经建议对通过加速审批程序批准的药物的医疗保险支付进行改革,因为人们担心完成验证性试验。 同样,我们不讨论增加医疗保险收入的选择,比如增加税收,因为MedPAC没有提出相关建议。然而,考虑到人口结构的预计变化,政策制定者可能会选择将收入纳入支持医疗保险偿付能力的一部分。这强调了有效利用医疗保险资源的必要性。TM计划为受益人提供了广泛的提供者选择(绝大多数医院和医生参与),但不提供标准一揽子计划之外的任何额外福利。相比之下,私人医疗保险优势(MA)计划可能要求参保人从网络内的医疗服务提供者那里获得医疗服务,并使用使用管理工具(如事先授权),但它们也提供了一系列TM不包括的额外福利。在过去的十年中,MA的注册人数大幅增长,大多数拥有a部分和B部分保险的受益人现在都在MA计划中。在一些市场,MA的参与率超过80%。当私人计划被加入医疗保险计划时,它们被视为一种既可以节省计划开支(通过管理服务使用和潜在地协商更优惠的支付率)又可以为参保人提供额外福利(这将使用计划节省的一部分资金)的方式。然而,MedPAC发现,总的来说,医疗保险优势计划(及其前身)从来没有节省过医疗保险资金——支付给计划的费用总是高于医疗保险在TM中为相同受益人支付的费用。2024年3月,委员会估计,MA计划的支付比TM成本高22%,主要原因是相对编码强度和对支出低于预期的受益人的有利选择这些较高的支付使得MA计划为MA参与者提供越来越慷慨的补充福利和更好的财务保护,例如更低的成本分摊和更低的保费。这导致了文学硕士入学人数的稳步增长。除了这些建议外,MedPAC还承认,如果硕士入学人数继续增长,则需要对硕士项目进行更根本的重新设计,因为基于萎缩的TM项目设定MA基准将变得越来越有问题。决策者可能需要考虑竞争性招标、使用MA数据设置付款或使用管理基准等选项。60年来,医疗保险一直是美国社会保险制度的支柱。它为一代又一代的美国人提供了免于疾病的经济保障,并使他们能够获得所需的护理。然而,随着婴儿潮一代进入该计划,医学科学继续产生重要的、改善健康的创新,这些创新必须得到资助,医疗保险计划需要继续发展,以促进有效的医疗服务,同时继续确保获得和财政保护。没有灵丹妙药,但上述方法提出了一些方法,可以提高对高效提供医疗服务的激励,改善受益人获得高质量医疗服务的机会,增加竞争,改善项目的财政状况。
期刊介绍:
Health Services Research (HSR) is a peer-reviewed scholarly journal that provides researchers and public and private policymakers with the latest research findings, methods, and concepts related to the financing, organization, delivery, evaluation, and outcomes of health services. Rated as one of the top journals in the fields of health policy and services and health care administration, HSR publishes outstanding articles reporting the findings of original investigations that expand knowledge and understanding of the wide-ranging field of health care and that will help to improve the health of individuals and communities.